Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Advanced Cancer × Olanzapine × 1 year × Clear all

Sponsor

Conditions

Neoplasms 5 Vomiting 3 Nausea 2 Anorexia 2 Weight Loss 1 Squamous Cell Carcinoma of Head and Neck 1 Opioid-Related Disorders 1 Muscular Atrophy 1 Lung Neoplasms 1 Hematologic Neoplasms 1 Gynecologic Cancer 1 Gliosarcoma 1 Glioblastoma 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Child Nutrition Disorders 1 Cachexia 1 Breast Neoplasms 1

Interventions

Nivolumab 6 Ipilimumab 2 Gemcitabine 2 zaleplon 1 temsirolimus 1 relatlimab 1 regorafenib 1 linrodostat 1 Vorinostat 1 Trastuzumab 1 Standard of Care 1 Sirolimus 1 Rehabilitation 1 Paclitaxel 1 Oxaliplatin 1 Injections 1 IFL protocol 1 Health Services Needs and Demand 1 Everolimus 1 Clinical Trials, Phase IV as Topic 1 Cisplatin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡